3 Stocks Tied To Aging At Home That Retail Investors May Want To Watch

An aging world is quietly rewiring where money flows, as governments brace for higher pension and healthcare costs and households shift spending toward care, comfort and medical support at home. That slow demographic turn creates pressure for some assets and potential openings in others. This article walks through three stocks from our Global Medtech and Home-Care Equipment for Aging Populations screener that appear positively exposed to this theme and may deserve a closer look.

The three stocks highlighted next are just a sample, and the full screen surfaced 15 more companies with equally compelling narratives that do not fit into this short article. To identify potential high-conviction ideas aligned with aging and home-care themes, head straight into the Global Medtech and Home-Care Equipment for Aging Populations screener.

Cofoe Medical TechnologyLtd (SZSE:301087)

Overview: Cofoe Medical TechnologyLtd develops and sells home care medical devices in China, serving elderly and chronically ill patients in domestic settings.

Market Cap: CN¥11.08b

Cofoe Medical TechnologyLtd is closely linked to the aging at home theme in China, with products that cover monitoring, respiratory support and rehabilitation equipment used outside hospitals. The stock trades on a lower P/E multiple than many local medical equipment peers while targeting an end market that has been growing quickly. However, one unresolved funding pressure could significantly influence how much of that demand translates into durable returns.

That funding question is central, so it is worth scanning the 5 key rewards and 2 important warning signs (1 is major!) to see what might be amplifying or capping the upside for Cofoe Medical TechnologyLtd.

Arjo (OM:ARJO B)

Overview: Arjo develops medical devices and services that support patient mobility, hygiene and handling for hospitals and long-term eldercare facilities worldwide.

Operations: The business reports SEK4.1b from North America, SEK6.4b from Global Sales and SEK411 million from Diagnostic, with small eliminations.

Market Cap: SEK7.3b

Arjo matters for the aging-population theme because its equipment sits directly in the care pathways where frailer patients need safe movement, hygiene and monitoring every single day.

"The accelerating shift toward home-based care and outpatient services threatens to structurally decrease demand for capital-intensive, facility-based solutions. This risks meaningful long-term revenue stagnation as Arjo's portfolio remains predominantly geared toward institutional settings."

The key question is how Arjo responds if a single assumption about where complex eldercare is delivered starts to break.

If that core assumption feels fragile, read the full narrative for Arjo to see how Arjo could still accelerate value creation as care models continue to shift.

Viemed Healthcare (VMD)

Overview: Viemed Healthcare provides home based respiratory care and medical equipment that help elderly and chronically ill patients receive treatment at home instead of in hospitals.

Operations: Viemed Healthcare generates all its US$301.6 million revenue from sleep and respiratory disorders in the United States, tightly focused on home based care.

Market Cap: US$348 million

Viemed Healthcare plugs directly into the aging at home theme by turning complex respiratory and sleep care into something that can be delivered in the living room instead of a hospital bed. The most interesting aspect is how its newer services might change the economics of that care.

"Acceleration in sleep PAP setups following the rollout of the Tenor intake partner, which cut PAP order qualification times to under an hour and supported a 16% sequential increase in PAP setups in Q2 2026 without extra fulfillment infrastructure, could allow Viemed Healthcare to add recurring sleep revenue at a faster pace than modeled and support higher revenue per dollar of SG&A.

What really matters next is how one quiet shift inside that model filters through to margins and the pace of future cash returns.

When that shift in economics matters this much, the full narrative for Viemed Healthcare shows how Viemed Healthcare could convert faster setups into stronger home-care cash generation with risks clearly mapped.

Seeking Fresh Alternatives Before The Crowd

Some opportunities only look obvious after they have already broken out. Scan fresh ideas while the momentum is still forming, before they stop flying under the radar. Act now.

• Spot income workhorses early and comb through 162 dividend fortresses, built to highlight high-yield payers that still keep balance sheets and payout profiles in clear view.
• Hunt for future infrastructure winners and run through the 40 power grid technology and infrastructure stocks to track companies linked to grid upgrades while that theme is still taking shape.
• Zero in on resilient operators by scanning the 226 resilient stocks with low risk scores, curated to surface businesses with sturdier risk profiles and fewer unpleasant financial surprises.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com